LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,344 | -69.7% | 81,967 | -36.4% | 0.00% | – |
| Q2 2023 | $295,223 | -5.3% | 128,919 | +0.5% | 0.00% | – |
| Q1 2023 | $311,795 | +31.1% | 128,311 | +3.1% | 0.00% | – |
| Q4 2022 | $237,766 | -27.5% | 124,484 | -8.9% | 0.00% | -100.0% |
| Q3 2022 | $328,000 | +26.6% | 136,683 | -1.9% | 0.00% | – |
| Q2 2022 | $259,000 | -6.8% | 139,377 | +4.8% | 0.00% | – |
| Q1 2022 | $278,000 | -33.0% | 133,049 | +26.2% | 0.00% | -100.0% |
| Q4 2021 | $415,000 | -25.6% | 105,419 | -9.1% | 0.00% | 0.0% |
| Q3 2021 | $558,000 | +49.2% | 115,914 | +42.1% | 0.00% | 0.0% |
| Q2 2021 | $374,000 | -18.2% | 81,589 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $457,000 | +90.4% | 77,918 | +10.9% | 0.00% | – |
| Q4 2020 | $240,000 | +142.4% | 70,229 | +2.0% | 0.00% | – |
| Q3 2020 | $99,000 | -23.8% | 68,860 | +5.8% | 0.00% | – |
| Q2 2020 | $130,000 | +3.2% | 65,079 | -0.4% | 0.00% | – |
| Q1 2020 | $126,000 | -57.7% | 65,341 | -9.4% | 0.00% | -100.0% |
| Q4 2019 | $298,000 | +31.3% | 72,135 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $227,000 | -52.0% | 74,039 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $473,000 | -14.9% | 74,209 | -24.9% | 0.00% | -50.0% |
| Q1 2019 | $556,000 | -21.1% | 98,787 | -7.1% | 0.00% | 0.0% |
| Q4 2018 | $705,000 | -53.8% | 106,345 | -26.5% | 0.00% | -50.0% |
| Q3 2018 | $1,526,000 | -1.7% | 144,694 | +11.9% | 0.00% | -20.0% |
| Q2 2018 | $1,553,000 | +72.2% | 129,264 | +23.5% | 0.01% | +66.7% |
| Q1 2018 | $902,000 | +1.0% | 104,656 | +15.9% | 0.00% | 0.0% |
| Q4 2017 | $893,000 | -9.5% | 90,278 | +12.3% | 0.00% | 0.0% |
| Q3 2017 | $987,000 | -16.3% | 80,419 | +12.3% | 0.00% | -25.0% |
| Q2 2017 | $1,179,000 | +6.6% | 71,586 | -7.5% | 0.00% | 0.0% |
| Q1 2017 | $1,106,000 | +9.2% | 77,421 | +5.6% | 0.00% | 0.0% |
| Q4 2016 | $1,013,000 | -19.6% | 73,287 | +5.0% | 0.00% | -33.3% |
| Q3 2016 | $1,260,000 | +41.6% | 69,790 | +12.6% | 0.01% | +50.0% |
| Q2 2016 | $890,000 | -0.2% | 61,989 | -7.4% | 0.00% | -20.0% |
| Q4 2015 | $892,000 | +21.4% | 66,971 | -2.2% | 0.01% | +25.0% |
| Q3 2015 | $735,000 | -26.6% | 68,478 | -45.0% | 0.00% | +33.3% |
| Q2 2015 | $1,002,000 | – | 124,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |